Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Clonidine Dosing for Hyperhidrosis

Dosage Recommendations

  • The American College of Cardiology recommends oral clonidine for hyperhidrosis, typically dosed at 0.1 mg/day to 0.4 mg/day, divided into two daily doses 1
  • The effective dose range is typically 0.1-0.4 mg per day, with most patients responding to approximately 0.3 mg daily 1
  • Higher doses (up to 0.8 mg daily) may be used in some cases but are generally not recommended due to increased risk of side effects 2, 3

Administration Considerations

  • Dividing the daily dose into two administrations (BID) is recommended to maintain steady blood levels 2, 3
  • Transdermal clonidine patches (0.1-0.3 mg released weekly) are available but less commonly used for hyperhidrosis 2, 3

Important Precautions and Monitoring

  • Clonidine is generally reserved as a later-line treatment option due to significant CNS adverse effects, especially in older adults 2, 3
  • Blood pressure monitoring is recommended as clonidine is primarily an antihypertensive medication 2, 3
  • Avoid abrupt discontinuation of clonidine, which may induce hypertensive crisis; the medication must be tapered to avoid rebound hypertension 2, 3
  • Common side effects include dry mouth, drowsiness, dizziness, and sedation 1, 2, 3
  • Doses used for treating hyperhidrosis do not typically affect blood pressure in normotensive individuals 1

Special Populations

  • Use with caution in elderly patients due to increased risk of CNS side effects 2, 3
  • In pregnancy, clonidine should be used with caution and only after careful risk-benefit assessment 4
  • For children with hyperhidrosis, lower doses based on weight may be considered, though evidence is limited 5

Comparative Efficacy

  • Clonidine appears to have mild to moderate efficacy in reducing excessive sweating, with studies showing reduction of hot flashes by up to 46% 1
  • Discontinuation rates due to side effects in clinical trials for hot flashes were approximately 40% for clonidine, compared to 10-20% for SSRIs/SNRIs 1